DANIEL BENDER: Open Payments
NPI 1265736664 · ORBISONIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,545 in 146 payments from 14 companies in 2025. Trend: 2023 $1,932 · 2024 $2,437 · 2025 $2,545
Food & beverage: $2,446Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $669 |
| Ardelyx, Inc. | 23 | $483 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $433 |
| Janssen Biotech, Inc. | 16 | $387 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $190 |
| Ipsen Biopharmaceuticals, Inc | 4 | $77 |
| Madrigal Pharmaceuticals | 2 | $73 |
| Lilly USA, LLC | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 7 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
Products named: IBSRELA, TREMFYA, ENTYVIO, RINVOQ, XIFAXAN, SKYRIZI, CREON, EOHILIA.
Industry payments across PA — which companies pay providers there.
